Overview of chronic cough.

The estimated global prevalence of chronic cough (CC) is close to 10%; however, this is likely higher, as many epidemiologic surveys do not adequately capture symptoms or diagnoses of CC. There is a large healthcare burden associated with CC as well as decreased quality of life (QOL). CC has previously been considered a symptom of other comorbidities.

Methods and Barriers to Communication Between Pharmacists During Transitions of Care.

Effective communication between pharmacists across healthcare settings is essential to facilitate transitions of care (TOC) and improve patient outcomes. To explore pharmacists' communication methods and preferences and identify barriers to communication during TOC. A survey was distributed to a convenience sample of pharmacists in California, Connecticut, Illinois, Massachusetts, New Jersey, and Texas.

Updates in treatment of adults with chronic cough.

Chronic cough is a severely debilitating condition that results in individuals coughing hundreds to thousands of times per day. Unfortunately, at the time of this writing, the majority of treatments currently available address acute cough and have minimal efficacy for chronic cough. There are no current FDA-approved pharmacologic treatments for chronic cough, resulting in a large, unmet need for patients.